These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30669140)

  • 1. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.
    Broers MC; Bunschoten C; Nieboer D; Lingsma HF; Jacobs BC
    Neuroepidemiology; 2019; 52(3-4):161-172. PubMed ID: 30669140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands.
    Broers MC; de Wilde M; Lingsma HF; van der Lei J; Verhamme KMC; Jacobs BC
    J Peripher Nerv Syst; 2022 Sep; 27(3):182-188. PubMed ID: 35567759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Chronic Inflammatory Demyelinating Polyneuropathy Epidemiology in Sardinia, Insular Italy.
    Sotgiu S; Onida I; Magli G; Castiglia P; Conti M; Nuvoli A; Carta A; Festa S; Dessì V; Doneddu PE; Nobile-Orazio E
    Neuropediatrics; 2021 Feb; 52(1):56-61. PubMed ID: 33111308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population.
    Rajabally YA; Simpson BS; Beri S; Bankart J; Gosalakkal JA
    Muscle Nerve; 2009 Apr; 39(4):432-8. PubMed ID: 19260065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of CIDP and the association of diabetes mellitus.
    Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
    Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
    Hu W; Xin Y; He Z; Zhao Y
    Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
    Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
    J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile.
    Cea G; Idiáquez JF; Salinas R; Matamala JM; Villagra R; Stuardo A
    J Clin Neurosci; 2020 Apr; 74():271-273. PubMed ID: 32067826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of chronic inflammatory neuropathies in southeast England.
    Mahdi-Rogers M; Hughes RA
    Eur J Neurol; 2014; 21(1):28-33. PubMed ID: 23679015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP).
    Querol L; Crabtree M; Herepath M; Priedane E; Viejo Viejo I; Agush S; Sommerer P
    J Neurol; 2021 Oct; 268(10):3706-3716. PubMed ID: 32583051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy.
    Chiò A; Cocito D; Bottacchi E; Buffa C; Leone M; Plano F; Mutani R; Calvo A;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1349-53. PubMed ID: 17494979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide for Treatment of Refractory Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-analysis.
    Xiang Q; Cao Y; Song Z; Chen H; Hu Z; Zhou S; Zhang Y; Cui H; Luo J; Qiang Y; Wang Y; Shuai S; Yang Y; Yang M; Wei X; Xiong A
    Clin Ther; 2022 Aug; 44(8):1058-1070. PubMed ID: 35872028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
    Viala K
    Int J Neurosci; 2016 Sep; 126(9):777-85. PubMed ID: 26392214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen JA; Bril V
    Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy.
    ; Vallat JM
    Postgrad Med J; 2008 Jul; 84(993):378-81. PubMed ID: 18716018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
    Hu J; Sun C; Lu J; Zhao C; Lin J
    J Neurol; 2022 Mar; 269(3):1250-1263. PubMed ID: 34120208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.
    Michaelides A; Hadden RDM; Sarrigiannis PG; Hadjivassiliou M; Zis P
    Pain Ther; 2019 Dec; 8(2):177-185. PubMed ID: 31201680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
    Sun QL; Sun AP; Fu Y; Fan DS
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of hematopoietic stem cell transplantation treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
    Zheng Y; Hu J; Sun C; Zhao C; Lin J
    Eur J Neurol; 2023 Aug; 30(8):2570-2582. PubMed ID: 37170791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.